Cite
HARVARD Citation
Varvel, N. et al. (2023). Preclinical development of an EP2 antagonist for post-seizure cognitive deficits. Neuropharmacology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Varvel, N. et al. (2023). Preclinical development of an EP2 antagonist for post-seizure cognitive deficits. Neuropharmacology. p. . [Online].